Results 151 to 160 of about 47,485 (252)

Kava (<i>Piper methysticum</i> G. Forst) for Substance Use Disorders: A Review of Mechanism, Pharmacology, Clinical Evidence, and Therapeutic Potential. [PDF]

Nutrients
Krehl J, Mamallapalli JN, Xing C, Grundmann O.   +3 more
europepmc   +1 more source

Real‐World Status of Augmentation Therapy With Atypical Antipsychotics in Major Depressive Disorder: A Claims Database Study

Neuropsychopharmacology Reports, Volume 46, Issue 4, December 2026.
Using real‐world data, AAP augmentation patterns were evaluated in patients with MDD initially treated with antidepressant monotherapy. AAP augmentation therapy was initiated after a relatively long interval. Although only a small proportion of patients received this therapy, nearly half showed claims‐defined continuation for more than 6 months ...
Hikaru Hori, Yoshiyuki Shibasaki, Yuki Shiomi, Kazunari Niidome, Takuya Maekawa, Kenji Maeda, Daisuke Sekine, Norihiro Nakamichi, Ken Inada   +8 more
wiley   +1 more source

Assessment of the Acute Toxicity and Anxiolytic-Like Effect of α-Humulene in Adult Zebrafish (Danio rerio). [PDF]

Chem Biodivers
Borges AS, Barbosa IM, Maciel JB, Fonseca AMD, Guedes JM, Menezes JESA, Delmondes GA, Kerntopf MR, Santos HSD, Teixeira AMR.   +9 more
europepmc   +1 more source

UK Medical Cannabis Registry: A Two‐Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia

Neuropsychopharmacology Reports, Volume 46, Issue 4, December 2026.
Insomnia affects around one in ten adults. In this 2‐year UK Medical Cannabis Registry cohort study of 211 adults with insomnia, treatment with cannabis‐based medicinal products was associated with a sustained improvement in self‐reported sleep quality across 24 months.
Aran Koye, Simon Erridge, Evonne Clarke, Katy McLachlan, Ross Coomber, James J. Rucker, Mark W. Weatherall, Mikael H. Sodergren   +7 more
wiley   +1 more source

Exploring the Neuropharmacological Potential of Ligustrum sinense Relevant to Parkinson's Disease: In Vivo and In Silico Study. [PDF]

Chem Biodivers
Das S, Hamim SMI, Zilani MNH, Chhando KS, Das P, Hossain MR, Imtiaz M, Tasmin J, Miah R, Hasan MN.   +9 more
europepmc   +1 more source

Mānuka Honey and Leaf Bioactives: A Review of Taonga Natural Products From Leptospermum scoparium

New Zealand Journal of Botany, Volume 64, Issue 4, December 2026.
This comprehensive review of mānuka examines its cultural significance, botany, distinct genetics and unique phytochemistry. It highlights mānuka honey, enriched with antibacterial methylglyoxal derived from nectar dihydroxyacetone, and details markers used to combat honey fraud.
John W. van Klink, Suzanne M. Scheele, Nigel B. Perry   +2 more
wiley   +1 more source

Associations between psychiatric comorbidity and intensive care unit length of stay, hospital length of stay, and in‐hospital mortality: A retrospective observational study

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 4, December 2026.
Abstract Aim Psychiatric comorbidities are common among patients admitted to the intensive care unit (ICU), but findings regarding their impact on clinical outcomes remain inconsistent. Additionally, existing studies have often included patients admitted for suicide attempts or self‐harm, leaving insufficient evidence about the independent effects of ...
Toshinori Nakamura, Takumi Momma, Tomonari Yoshizawa, Yusuke Arai, Daimei Sasayama, Atsuyoshi Mita, Hiroshi Imamura, Ryota Hashimoto, Shinsuke Washizuka   +8 more
wiley   +1 more source

Pediatric psychotropic prescribing and polypharmacy, 2019-2022: a retrospective electronic health record study in Qatar. [PDF]

Front Psychiatry
Abo El-Ella DM, Dhieb D, Kanan Y, Hamad S, Bastaki K.   +4 more
europepmc   +1 more source